Surprise surprise - how come European countries haven't immediately suspended it while it's investigated like they did with Astrazeneca ? Oh wait ... because it's their solution to catching up with vaccination rates as a single dose vaccine and isn't linked to UK supply rows ! Same tech, almost certainly same minute risk.
EMA reviewing possible link between Johnson & Johnson vaccine and rare blood clots
Here some more detail on the news that Europe’s drugs regulator EMA is reviewing reports of a bleeding condition in people after receiving AstraZeneca’s Covid-19 vaccine and looking into Johnson & Johnson’s shot over reports of rare blood clots.
Reuters reports:
J&J told Reuters it was aware that thromboembolic events including those with thrombocytopenia have been reported in all Covid-19 vaccines, but that, at present, no clear causal relationship has been established between these rare events and its vaccine.
The company added it was working closely with experts and regulators to assess data on blood clots occurring in people who had its vaccine.
Well, at least EMA has approved 4 vaccines for use, including the J&J (EU has approved more vaccines than UK, US, ect.). Why is UK delaying it? Maybe somebody needs to cash in first.